◆ 会议时间:2023年10月5-8日
◆ 会议地点:荷兰 阿姆斯特丹
◆ 会议简介:
2023年第23届欧洲视网膜专家学会(EURETINA)大会/年会将于2023年10月5-8日在荷兰阿姆斯特丹举行,预计有来自世界各地的5000余名专业人士与会。
欧洲视网膜专家学会(EURETINA)成立于1999年,由对治疗黄斑以及玻璃体视网膜疾病感兴趣的临床医生、科学家和研究者组成。EURETINA的宗旨是促进欧洲玻璃体视网膜和黄斑专家之间的知识交流并建立个人联系;支持和促进欧洲在玻璃体视网膜和黄斑方面的研究;将相关专业知识传播给普通眼科医师;与欧洲之外的类似相关团体保持联系。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
23rd Congress of the European Society of Retina Specialists (EURETINA2023)
Date: 5-8 October 2023
Venue: RAI Amsterdam, The Netherlands
摘要征文投稿:
Free Paper/e-Poster/Video Competition Abstract submission:
– Opens 9 January / Closes 13 March 2023
Submit Abstract
You must be logged in as a Member to access the form.
Free Paper
Terms & Conditions
– The Free Paper submission portal opens Monday 9th January and will close on Monday 13th March (23:59 CET).
– Please note that you must be a EURETINA Member in order to submit a Free Paper abstract.
– Free Paper abstracts will be considered for 5-minute presentation slots in Free Paper Sessions OR as Audio Narrated Free Papers available online and on designated computer terminals in the congress centre, depending on review outcome.
– Each applicant may submit a maximum of 2 Free Paper abstracts.
– If you wish to withdraw your abstract from the congress programme, you must confirm via email to programme@euretina.org by Friday 22nd September 2023.
If you choose to submit an abstract(s) we will use your personal details to keep you updated on its status including whether it has been accepted for presentation at the Euretina Congress. If your abstract(s) is accepted for presentation at the Euretina Congress your contact details (name and email address) will be sent to a third-party Audio-Visual Company in order for them to contact you in relation to uploading your presentation.
Review & Evaluation
– All submitted abstracts will be reviewed before final selection is made with submissions ranked according to their average score.
– Specific topics that need to be covered in the congress programme will be
considered before making the final selection of accepted abstracts. The decision of the Euretina Review Committee is final.
– If your abstract is accepted, you will be informed of this by email by the end of May 2023.
– It is not possible to reschedule the assigned time of an accepted Free Paper.
Abstract Submission
All submitted abstracts must be in English and follow the structured format below:
– Title (250 characters max)
– Purpose (100 words max)
– Setting/Venue (50 words max)
– Methods (200 words max)
– Results (200 words max)
– Conclusions (200 words max)
All abstracts MUST be submitted in the presenting author’s name.
Financial Disclosure: Please indicate Yes/No with details where applicable.
Further Instructions
– The summary of results presented must be given in sufficient detail to support the conclusions. The Review Committee will only accept abstracts with final results or conclusions.
– Formulae should, in general, be avoided.
– When using abbreviations or acronyms for the first time, care should be taken to spell them out in full with the abbreviation in parentheses after the full word(s) the first time it appears in the text. The abbreviation should be used alone thereafter.
– Indicate whether the presenting author or any co-author has a financial interest in the subject matter or receives money from any mentioned company.
E-Poster
Terms & Conditions
– The E-Poster submission portal opens Monday 9th January and will close on Monday 13th March (23:59 CET).
– Please note that you must be a EURETINA Member in order to submit an E-Poster abstract.
– E-Posters will be considered for display on designated computer terminals located throughout the conference centre OR as quick fire 4-minute presentations in the Euretina Speakers’ Corner, depending on review outcome.
– Each applicant may submit a maximum of 2 E-Poster abstracts.
– If you wish to withdraw your abstract from the congress programme, you must confirm via email to programme@euretina.org by Friday 22nd September 2023.
If you choose to submit an abstract(s) we will use your personal details to keep you updated on its status including whether it has been accepted for presentation at the Euretina Congress. If your abstract(s) is accepted for presentation at the Euretina Congress your contact details (name and email address) will be sent to a third-party Audio-Visual Company in order for them to contact you in relation to uploading your presentation.
Review & Evaluation
– All submitted abstracts will be reviewed before final selection is made with submissions ranked according to their average score.
– Specific topics that need to be covered in the congress programme will be
considered before making the final selection of accepted abstracts. The decision of the Euretina Review Committee is final.
– If your abstract is accepted, you will be informed of this by email by the end of May 2023.
Abstract Submission
All submitted abstracts must be in English and follow the structured format below:
– Title (250 characters max)
– Purpose (100 words max)
– Setting/Venue (50 words max)
– Methods (200 words max)
– Results (200 words max)
– Conclusions (200 words max)
All abstracts MUST be submitted in the presenting author’s name.
Financial Disclosure: Please indicate Yes/No with details where applicable.
Further Instructions
– The summary of results presented must be given in sufficient detail to support the conclusions. The Review Committee will only accept abstracts with final results or conclusions.
– References and credits cannot be included as part of an abstract.
– When using abbreviations or acronyms for the first time, care should be taken to spell them out in full with the abbreviation in parentheses after the full word(s) the first time it appears in the text. The abbreviation should be used alone thereafter.
– Indicate whether the presenting author or any co-author has a financial interest in the subject matter or receives money from any mentioned company.
注册费:
Registration Fees In Person Attendance
Prices are in Euro & listed without VAT.
Dutch VAT is charged at 21% |
Early Fee
Available until 31 July |
Late Fee
1 August – 3 October |
Onsite Fee
4 – 8 October |
EURETINA Member |
€300 |
€350 |
€400 |
Non-Member |
€450 |
€500 |
€550 |
Trainee Member* |
€145 |
€190 |
€240 |
Trainee Non-Member* |
€170 |
€210 |
€260 |
Allied Healthcare Professional* |
€150 |
€175 |
€225 |
Ophthalmic Nurse/Technician* |
€100 |
€150 |
€200 |
Corporate |
€1100 |
€1300 |
€1500 |
*Documentation such as a work ID or verification letter from your hospital is required and must be uploaded during the registration process for approval.
Corporate fees are standard across virtual and face to face registrations.
Delegates from Ukraine will receive complimentary registration. Proof of eligibility required in the form of a National ID, Passport or driver’s license.
Registration Fees Virtual Access Only
Prices are in Euro & listed without VAT.
UK VAT is charged at 20% |
Early Fee
Available until 31 July |
Late Fee
1 August – 3 October |
Onsite Fee
4 – 8 October |
EURETINA Member |
€300 |
€350 |
€400 |
Non-Member |
€450 |
€500 |
€550 |
Trainee Member* |
€145 |
€190 |
€240 |
Trainee Non-Member* |
€170 |
€210 |
€260 |
Allied Healthcare Professional* |
€150 |
€175 |
€225 |
Ophthalmic Nurse/Technician* |
€100 |
€150 |
€200 |
Corporate |
€1100 |
€1300 |
€1500 |
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|